Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed a new medical imaging tool, “fast-RSOM,” that can detect heart disease years before it develops.The ...

The intake of oral semaglutides such as Wegovy or Rybelsus among adults with type 2 diabetes (T2D) was associated with a reduced risk of heart failure (HF) compared to those who took a placebo, ...

Heart & Stroke has released a new report offering a clear picture of the growing risks to heart and brain health in Canada. Titled By the numbers: the state of risk factors for heart disease and ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

"Clinical practice must move beyond the outdated notion that women are simply 'small men.'" ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

On behalf of the CardiAMP HF investigators, the presentation will be made by Dr. Amish Raval, M.D., Professor of Medicine at UW School of Medicine and Public Health and CardiAMP HF Trial National ...

A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels — a quiet warning ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

A normal coronary angiogram does not always guarantee safety from a heart attack. Conditions like microvascular disease, ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a ...